Kenneth G. Digiacomo - Manasquan NJ Satyanarayana Dosapati - Marlboro NJ Chia-Chang Li - Holmdel NJ John S. Tsai - Colts Neck NJ
Assignee:
AT&T Corporation - New York NY
International Classification:
H04L 900
US Classification:
713201
Abstract:
A communication system and method utilizing a divided customer Internet Protocol (IP) address space for access customer premises equipment (CPE) addresses and customer personal computer addresses. Both the access CPE and the customer personal computers are located at a customer premises. Using the system and method, Internet service providers can easily implement security measures to deny access to a Network Operation Center (NOC) by communications originating from customer personal computers but allow communications between the NOC and the access CPE.
Hydrolyzed Zein As Hair Fixative In Hair Compositions
Natalie Morawsky - Highland Park NJ Gary T. Martino - Plainsboro NJ Jacob Guth - Upper Darby PA John Tsai - Belle Mead NJ Roger Jeffcoat - Bridgewater NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
A61K 711 A61K 3578
US Classification:
424 7014
Abstract:
This invention relates to hair fixing compositions containing a natural based hydrolyzed zein fixative which has a selected molecular weight, the composition having low volatile organic compound (VOC) content.
Water Resistant Alkaline Corrugating Adhesive Composition And Paperboard Product Produced Therewith
Craig H. Leake - Edison NJ John J. Tsai - Belle Mead NJ Eric A. Meier - Hamilton Sq. NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
C08J 310 C08L 304 C08L 5102
US Classification:
524 30
Abstract:
A water resistant, starch-based alkaline corrugating adhesive which includes a polysaccharide graft copolymer containing a reactive aminoethyl halide group.
Dr. Tsai graduated from the Northwestern University Feinberg School of Medicine in 2001. He works in Tucson, AZ and 1 other location and specializes in Gastroenterology. Dr. Tsai is affiliated with Carondelet Saint Josephs Hospital and Cornerstone Hospital Of Southeast Arizona.
Dr. Tsai graduated from the George Washington University School of Medicine and Health Science in 1998. He works in Centreville, VA and 1 other location and specializes in Pediatrics and Adolescent Medicine. Dr. Tsai is affiliated with Inova Fair Oaks Hospital.
Dr. Tsai graduated from the Ohio State University College of Medicine in 1987. He works in Massillon, OH and specializes in Cardiovascular Disease. Dr. Tsai is affiliated with Mercy Medical Center.
Kaiser Permanente Medical GroupKaiser Permanente Anesthesiology 9300 Imperial Hwy, Downey, CA 90242 (562)4613000 (phone), (562)6579953 (fax)
Education:
Medical School Albert Einstein College of Medicine at Yeshiva University Graduated: 1997
Languages:
English
Description:
Dr. Tsai graduated from the Albert Einstein College of Medicine at Yeshiva University in 1997. He works in Downey, CA and specializes in Pediatric Anesthesiology.
Physics Teacher at Townsend Harris High School, Computer/Network Administrator and Technology Coordinator at Townsend Harris High School
Location:
Greater New York City Area
Industry:
Education Management
Work:
Townsend Harris High School since Oct 2001
Physics Teacher
Townsend Harris High School since 2001
Computer/Network Administrator and Technology Coordinator
RTS Wireless/Aether Systems Aug 1998 - Jun 2001
Programmer/DBA
Reuters Feb 1992 - Aug 1998
Project Lead
GE Aerospace Aug 1990 - Feb 1992
Programmer
Education:
Stevens Institute of Technology 1988 - 1989
MS, Computer Science
Columbia University in the City of New York 1982 - 1986
BS, EE
nchise and Global Head of Medical Affairs for the Pharmaceuticals business unit. Dr. Aradhye will report to Vas Narasimhan and join the ECN. With the changes in organizational structure and operating model, John Tsai, M.D., has decided to pursue opportunities outside Novartis effective May 15th, 2022.
Date: Apr 04, 2022
Category: Business
Source: Google
Novartis to test hydroxychloroquine for coronavirus
We recognise the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease, said John Tsai, head of Global Drug Development and chief medical officer at Novartis. We mobilised quickly to address this question in a randomise